Provided by Tiger Trade Technology Pte. Ltd.

Processa Pharmaceuticals, Inc.

2.38
+0.21009.68%
Post-market: 2.37-0.0100-0.42%18:58 EST
Volume:58.35K
Turnover:137.41K
Market Cap:5.39M
PE:-0.07
High:2.45
Open:2.14
Low:2.10
Close:2.17
52wk High:19.63
52wk Low:2.05
Shares:2.27M
Float Shares:1.96M
Volume Ratio:0.65
T/O Rate:2.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-34.9992
EPS(LYR):-96.8176
ROE:-270.74%
ROA:-129.94%
PB:0.92
PE(LYR):-0.02

Loading ...

Processa Pharmaceuticals Completes Enrollment for Interim Analysis in Phase 2 Breast Cancer Study

Reuters
·
Jan 05

Processa Pharmaceuticals Resumes Trading, Stock up 106.5%

THOMSON REUTERS
·
Dec 18, 2025

Processa Pharmaceuticals Halted for Volatility

THOMSON REUTERS
·
Dec 18, 2025

Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?

Benzinga_recent_news
·
Dec 18, 2025

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 11:16 AM

Reuters
·
Dec 18, 2025

Processa Pharmaceuticals Reports Promising Phase 2 Data for NGC-Cap in Metastatic Breast Cancer

Reuters
·
Dec 17, 2025

Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer

THOMSON REUTERS
·
Dec 17, 2025

Processa Pharmaceuticals Inc -Prelim Phase 2 Data Show Pcs6422+Capecitabine Increased Cancer-Killing Metabolite Exposure

THOMSON REUTERS
·
Dec 17, 2025

Processa Pharmaceuticals Inc - on Track to Conduct Formal Interim Analysis in Early 2026

THOMSON REUTERS
·
Dec 17, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Dec 17, 2025

BRIEF-Processa Pharmaceuticals To Effect 1-For-25 Reverse Stock Split

Reuters
·
Dec 16, 2025

Processa Pharmaceuticals Inc - on Dec 12, Files Certificate of Amendment to Co's Fourth Amended and Restated Certificate of Incorporation

THOMSON REUTERS
·
Dec 16, 2025

Processa Pharmaceuticals Inc - to Effect 1-for-25 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Dec 16, 2025

Processa Pharmaceuticals Enacts 1-for-25 Reverse Stock Split

Reuters
·
Dec 16, 2025

Analysts Offer Insights on Healthcare Companies: Processa Pharmaceuticals (PCSA) and Decibel Cannabis Company (OtherDBCCF)

TIPRANKS
·
Nov 20, 2025

Processa Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
Oct 24, 2025

Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight?

Benzinga
·
Oct 08, 2025

Processa Pharmaceuticals Inc. Concluded Special Shareholder Meeting

Reuters
·
Sep 12, 2025

Processa Pharmaceuticals Inc. Held Special Shareholder Meeting

Reuters
·
Sep 03, 2025

Processa Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 02, 2025